Intraoperative Neuromonitoring Market size is valued at $1098.23M by 2019, and is estimated to reach $1,489.12M by 2025, growing at CAGR of 5.3% during the forecast period of 2020-2025. The Intraoperative Neuromonitoring Market growth rate is attributed to the increasing emphasis on patient safety during complicated surgeries which can be co-related to the growing prevalence of various lifestyles associated chronic diseases such as neurological and cardiovascular conditions that demands ultimate patient safety during the performance of these complicated surgeries thereby, fostering the market growth. Intraoperative monitoring is becoming a crucial factor in neurosurgery as it offers an early warning concerning motor & sensory functions during surgery thus yielding better results and avoiding post-operative neurophysiological deficits thus reducing risks of debilitating deficits such as muscle weakness, paralysis, hearing loss, and other normal body functions. Safer surgery translates to reduced intervention time and risk. An IONM system uses recordings of potentials (such as EEG, EMG, and evoked potentials) from the nervous system during a surgical procedure. These benefits have made it mandatory in neurosurgeries. From technological advancements in neuromonitoring have helped the surgeons to minimize the risks during surgery, when the central nervous system (CNS) is at risk to increased R&D investments by governmental bodies to overcome limitations of high cost thereby launching advanced products in the field of neuromonitoring is anticipated to propel the Intraoperative Neuromonitoring Market during the forecast period 2020-2025.   

The report: “Intraoperative Neuromonitoring Market Forecast (2020-2025)”, by Industry ARC, covers an in-depth analysis of the following segments of the Intraoperative Neuromonitoring Market: 

By Source Type:  Outsource Monitoring and Insource Monitoring.

By Modality: Electroencephalography(EEG), Electromyography(EMG) and Electrophysiology(EP).

By Application: Spinal Surgery, ENT Surgery, Neurosurgery, Vascular Surgery, Orthopedic Surgery and Others.

By End-Use: Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Others.

By Geography: North America, Europe, Asia-Pacific and RoW.

Insource IONM segment held the largest share in the market owing rising number of surgeries and compulsory monitoring of vital stats during every procedure. Also, Hospitals have adopted IONM systems and have trained technologists, who are supervised by neurologists and physiologists during the procedures. Moreover, there are no defined guidelines for the use of these neuromodulation devices but growing demand and usage of the same is anticipated to trigger the segmental growth.

However, Outsource IONM is gaining popularity and is anticipated to be the fastest-growing segment in the forecast period 2020-2025; this can be attributed to the fact that outsourcing devices eliminates the need for hospitals to incur capital expenditure for the purchase of the equipment’s and bear its maintenance cost. Apart from this, now-a-days, hospitals generally do not prefer insourced monitoring as they have to appoint a full-time employee with the required skill set and they cannot offer the training standardization that is required to improve the quality of service. Thus, outsourced monitoring is in demand among hospitals and ASCs. In addition, IONM professionals also prefer to work for an outsourcing provider as they can work simultaneously for more than one hospital by working in an outsourcing IONM provider.

   

Based on Application type, spinal surgery segment held the major share of the market in terms of revenue and is set to grow with a CAGR of 6.0%. The reason is set to be attributed to the fact that spinal surgery is widely used to treat spinal pathologies, and is the gold standard for correcting spinal deformities, but despite improvements in surgical techniques, the risk of neurological complications remains. Moreover, IONM is also utilized for other spine surgery indications: tethered cord, injured spinal cord, intramedullary tumors, extra medullary tumors, minimally-invasive surgery, cervical myelopathy, as well in other fields of surgery: cranial, vascular, cardiothoracic, etc. and is helpful in preventing perioperative peripheral nerve injury (PPNI) owing to excess mechanical pressure and torsion of the limbs and neck, which is anticipated to further expand the market over the projection period of 2020-2025. As per a report published by NCBI, it states that during CEA up to 15% of patients experience cerebral hypoperfusion after carotid cross clamping. This hypoperfusion leads to changes in electrophysiological signals in the brain, such as a decrease in fast EEG activities and a decrease in the amplitude or increase in the latencies of SSEP. Thus, IOM can help detect patients who is set to eventually require a selective shunt during the CEA procedure.

North America is the major region dominating the Intraoperative Neuromonitoring market with revenue of $570.42M in 2019 and is estimated to grow at a CAGR of 4.7% during the forecast period of 2020-2025 to generate revenue of $ 745.23M in 2025. There is a rise in the usage the region has surged cases of chronic ailments, emergence of exceptionally refined medicinal services framework, high selection rate of intraoperative neuromonitoring, and expanded patient awareness in regard to the procedure. Moreover, the region is anticipated to increase its market share in the future, owing to the favorable and constantly improving reimbursement scenario. Significant investment is done on R&D activities in U.S. Many neurological centers in the U.S. strongly recommend the use of IONM thereby, trying to fulfill the manpower gap to meet the demand. Hospitals encourage physicians and doctorate-level IONM providers to get certified from organizations such as the American Board of Nuclear Medicine. The healthcare system is also trying to encourage underemployed neuroscience PhDs to pursue a career in IONM and become full-time professionals.

Moreover, the intraoperative neuromonitoring in Asia Pacific is likely to observe the fastest growth over the forecast period 2020-2025 growing at a CAGR of 6.6% owing to the growing awareness in regards to intraoperative neuromonitoring in patients during complicated surgeries and development in medical tourism sector in the rising nations in the area, for example, India and China.

With leading manufacturers leveraging advanced technology to launch compact and portable IONM devices, which are capable of getting configured with any laptop or desktop in the global market. Tele-neuromonitoring enabled qualified and certified IONM professionals to monitor patients from remote locations effectively are the growing requirement of the era. Through remote-neuromonitoring, the certified technologist or the physician can continuously monitor all the vital data, including action potential amplitude value, blood pressure data, and the degree of muscle relaxation. Remote monitoring also helps doctors reach small communities and rural areas and provide superior healthcare services from remote locations. Several hospitals and clinics also rely on tele-neuromonitoring, where a certified medical professional can provide high-quality monitoring service from any distant location and help save lives in the global market hence, can be considered as an Intraoperative Neuromonitoring key driver of the market during the forecast period 2020-2025. 

  

The major challenge for the market is the high initial capital investment required for new production plant, R&D cost required adds additional cost for production of various intraoperative neuromonitoring devices and compliance of these products in a vast and heterogeneous market. The poor compliance is attributed to stringent government regulations which are anticipated to hamper growth of the global intraoperative neuromonitoring market as the devices undergo rigorous clinical trials prior to a PMA (premarket approval), which causes a significant rise in the costs incurred by the manufacturers; the main obstacle being the dearth of skilled professionals. 

Product launches, mergers and acquisitions, joint ventures and geographical expansions are key strategies adopted by players in the Intraoperative Neuromonitoring Market. In 2019, Intraoperative Neuromonitoring Market share is fragmented by the top ten players present in the market. Intraoperative Neuromonitoring Market top 10 companies are Accurate Monitoring LLC, Medtronic PLC, NuVasive Inc., Computational Diagnostics Inc., SpecialtyCare, Natus Medical Incorporated., IntraNerve LLC, AXIS Neuromonitoring, LLC, Synaptic Resources LLC, Bromedicon, Inc., Inomed Medizintechnik GmbH and others.